Product Name: Sustaver (Sustanon)
Active substance: testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, testosterone decanoate
Androgenic, anti-cancer, anabolic. Regulates the development of male reproductive organs and secondary sexual characteristics, the growth of bone and muscle, reduces fat accumulation and excretion of trace elements, inhibits the production and release of pituitary LH and FSH increases anabolism, and inhibits protein catabolism, increased exchange of nitrogenous substances in sufficient calorie protein diet, stimulating production of erythropoietin and erythropoiesis. T1 / 2 - from 10 to 100 min, 98% protein bound.
Androgen deficiency in men: a delay of puberty, oligospermia, post-castration syndrome, genital hypoplasia, infertility in violation of spermatogenesis, menopausal syndrome, impotence, osteoporosis. Women: hyperestrogenism, uterine fibroids, endometriosis, menopause (combined with estrogens), premenstrual tension syndrome, breast cancer, osteoporosis.
Contraindications and Cautions:
Hypersensitivity, known or suspected carcinoma of the prostate and / or breast cancer, nephrosis or nephrotic phase of nephritis, hypercalcemia, edema, liver and kidney disease, diabetes, prostate hypertrophy with symptoms of voiding dysfunction, cardiac and coronary insufficiency, previous myocardial infarction, atherosclerosis in elderly men, pregnancy, breast-feeding. When the side effects of androgen treatment should be stopped before their disappearance and resume reduced doses.
Precocious puberty, abnormal and cancer of the prostate, increased sexual arousal and more frequent erections, increased penis, priapism, oligospermia, decreased ejaculatory volume, sodium and water retention, premature closure of the growth areas of bones, headache, depression, anxiety, sleep disturbance, bleeding in the gastrointestinal tract, nausea, cholestatic jaundice, other androgenic effects (hirsutism, seborrhea, acne, etc.).
The optimum dosage for Sustaver 250 ml of 1 every 3 weeks, and depends usually on individual patient response. Acute overdose of the drug when administered intramuscularly causes no particular toxicity: a symptom of a chronic overdose is the development of priapism in men. In the event of prolonged painful erection unrelated to sexual stimulation, it is recommended to temporarily stop taking the drug, and after the disappearance of symptoms resume treatment Sustaver 250 at lower doses. For adults is administered intramuscularly 1 ml over 14 days to achieve the therapeutic - 1 ml intramuscular after 28 days. Duration of treatment is determined individually. Breast cancer in women: 1-2 ml every 1-2 weeks treatment period.
Enhances the effect of indirect anticoagulants (warfarin, nikumalon, fenilin) and hypoglycemic agents, inhibits the excretion of cyclosporine. Barbiturates and alcohol reduces the effect.
Store in a dry place protected from light, at a temperature of 15-25 ° C. Keep out of the reach and sight of children.